1. Home
  2. TROX vs SUPN Comparison

TROX vs SUPN Comparison

Compare TROX & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tronox Holdings plc (UK)

TROX

Tronox Holdings plc (UK)

HOLD

Current Price

$4.31

Market Cap

550.2M

Sector

Industrials

ML Signal

HOLD

Logo Supernus Pharmaceuticals Inc.

SUPN

Supernus Pharmaceuticals Inc.

HOLD

Current Price

$51.84

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TROX
SUPN
Founded
2018
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
550.2M
2.6B
IPO Year
2005
2012

Fundamental Metrics

Financial Performance
Metric
TROX
SUPN
Price
$4.31
$51.84
Analyst Decision
Hold
Strong Buy
Analyst Count
8
5
Target Price
$4.69
$61.60
AVG Volume (30 Days)
5.3M
690.1K
Earning Date
11-05-2025
11-04-2025
Dividend Yield
4.59%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,844,000,000.00
$681,539,000.00
Revenue This Year
N/A
$8.32
Revenue Next Year
$3.22
$23.36
P/E Ratio
N/A
N/A
Revenue Growth
N/A
4.54
52 Week Low
$2.86
$29.16
52 Week High
$10.67
$57.65

Technical Indicators

Market Signals
Indicator
TROX
SUPN
Relative Strength Index (RSI) 56.14 68.51
Support Level $4.29 $45.36
Resistance Level $4.61 $47.26
Average True Range (ATR) 0.32 1.47
MACD 0.02 0.70
Stochastic Oscillator 38.16 92.77

Price Performance

Historical Comparison
TROX
SUPN

About TROX Tronox Holdings plc (UK)

Tronox Holdings PLC is a vertically integrated manufacturer of TiO2 pigment. It operates titanium-bearing mineral sand mines and beneficiation and smelting operations in Australia & South Africa to produce feedstock materials that can be processed into TiO2 for pigment, high-purity titanium chemicals, including titanium tetrachloride, and ultrafine TiO2 used in certain specialty applications. TiO2 and titanium feedstock, are used to produce paints and coatings, as well as plastics, paper, and printing ink. It has three pigment production facilities in the United States, the Netherlands, and Western Australia and three mining operations in Western Australia and South Africa. Europe, the Middle East, and Africa regions contribute the majority of revenue.

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.

Share on Social Networks: